实体

Jul 18, 2026

• entity
• egfr
• her-family
• antibody-drug-conjugate

Jul 18, 2026

• entity
• breast-cancer
• her2-low

Jul 18, 2026

• t-dxd
• trastuzumab-deruxtecan
• entity

Jul 18, 2026

• antibody-drug-conjugate
• entity

Jul 18, 2026

• entity
• tumor-associated-macrophage
• myeloid-cell
• tumor-microenvironment

Jul 17, 2026

• gene
• brca
• homologous-recombination

Jul 17, 2026

• dato-dxd
• datopotamab-deruxtecan
• entity

Jul 17, 2026

• her2-positive-tumor
• entity

Jul 17, 2026

• drug
• parp-inhibitor
• olaparib

Jul 17, 2026

• drug-class
• parp-inhibitor
• dna-damage-response

Jul 17, 2026

• entity
• immune-checkpoint
• pd-l1
• cd274

Jul 17, 2026

• triple-negative-breast-cancer
• entity

Jul 17, 2026

• breast-cancer
• entity

Jul 17, 2026

• entity
• trastuzumab
• her2

Jul 17, 2026

• entity
• tumor-infiltrating-lymphocytes
• til
• breast-cancer

Jul 15, 2026

• entity
• drug
• pi3k-alpha-inhibitor
• breast-cancer

Jul 15, 2026

• drug-class
• cdk4-6-inhibitor
• breast-cancer

Jul 15, 2026

• her3
• erbb3
• entity

Jul 15, 2026

• entity
• breast-cancer
• hr-positive
• her2-positive

Jul 15, 2026

• breast-cancer
• hr-positive
• her2-negative
• metastatic

Jul 15, 2026

• gene
• protein
• dna-damage-response
• parp1

Jul 15, 2026

• drug-class
• pi3k-inhibitor
• breast-cancer

Jul 15, 2026

• breast-cancer
• pik3ca
• molecular-subtype

Jul 15, 2026

• entity
• tumor-suppressor
• pten
• pi3k-akt

Jul 15, 2026

• trop-2
• tacstd2
• entity

Jul 15, 2026

• drug
• parp-inhibitor
• veliparib